TGI (Targeted Granzyme B Immunotherapy) Poster Presented at the 2018 AACR Annual Meeting – Business Wire (press release)
|
TGI (Targeted Granzyme B Immunotherapy) Poster Presented at the 2018 AACR Annual Meeting
Business Wire (press release) CHICAGO–(BUSINESS WIRE)–Dr. Michael Rosenblum and his team at MD Anderson Cancer Center, Houston, TX, presented updated data on TGI (Targeted Granzyme B immunotherapy) at the 2018 American Association of Cancer Research Annual Meeting (AACR). The … |
